Clinical Trial Update: Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating long-term immunogenicity in children and adolescents five years after boosting with a pediatric tick-borne encephalitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tick-borne Encephalitis

Drugs mentioned

• Novartis pediatric Tick-Borne Encephalitis vaccine (Tick-borne encephalitis vaccine)

Snippet

Sponsor: Novartis | Conditions: Encephalitis, Tick-Borne | Phase 4 | Status: COMPLETED